Showing 15,241 - 15,260 results of 15,382 for search '"Plasmodium"', query time: 3.05s Refine Results
  1. 15241

    Multiplex Serology for Measurement of IgG Antibodies Against Eleven Infectious Diseases in a National Serosurvey: Haiti 2014–2015 by YuYen Chan, Diana Martin, Kimberly E. Mace, Samuel E. Jean, Gillian Stresman, Chris Drakeley, Michelle A. Chang, Jean F. Lemoine, Venkatachalam Udhayakumar, Patrick J. Lammie, Jeffrey W. Priest, Eric William Rogier

    Published 2022-06-01
    “…Filter paper blood samples (n = 4,438) were collected from participants in 117 locations and assayed for IgG antibodies on a multiplex bead assay containing 15 different antigens from 11 pathogens: Plasmodium falciparum, Toxoplasma gondii, lymphatic filariasis roundworms, Strongyloides stercoralis, chikungunya virus, dengue virus, Chlamydia trachomatis, Treponema pallidum, enterotoxigenic Escherichia coli, Entamoeba histolytica, and Cryptosporidium parvum.ResultsDifferent proportions of the Haiti study population were IgG seropositive to the different targets, with antigens from T. gondii, C. parvum, dengue virus, chikungunya virus, and C. trachomatis showing the highest rates of seroprevalence. …”
    Get full text
    Article
  2. 15242

    The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians by Lek Dysoley, Saorin Kim, Sergio Lopes, Nimol Khim, Steven Bjorges, Samphornarann Top, Chea Huch, Huy Rekol, Nelli Westercamp, Mark M. Fukuda, Jimee Hwang, Arantxa Roca-Feltrer, Mavuto Mukaka, Didier Menard, Walter R. Taylor

    Published 2019-03-01
    “…Abstract Background The WHO recommends single low-dose primaquine (SLDPQ, 0.25 mg/kg body weight) in falciparum-infected patients to block malaria transmission and contribute to eliminating multidrug resistant Plasmodium falciparum from the Greater Mekong Sub region (GMS). …”
    Get full text
    Article
  3. 15243

    Toxoplasma TgAtg8-TgAtg3 Interaction Primarily Contributes to Apicoplast Inheritance and Parasite Growth in Tachyzoite by Linyan Cheng, Yuan Tian, Yan Wang, Tingting Wang, Yinning Yao, Helin Yu, Xiaozi Zheng, Mimi Wu, Wei Zhao, Qianqian Hua, Xin Hu, Feng Tan

    Published 2022-02-01
    “…Intriguingly, autophagy-related protein 8 (Atg8), a highly conserved eukaryotic protein, can localize to the outermost membrane of the apicoplast and modulate its inheritance in both Toxoplasma and Plasmodium parasites. The Atg8-Atg3 interaction plays a key role in Atg8 lipidation and localization, and our previously work in Toxoplasma has suggested that the core Atg8-family interacting motif (AIM) in TgAtg3, 239FADI242, and the R27 residue of TgAtg8 contribute to TgAtg8-TgAtg3 interaction in vitro. …”
    Get full text
    Article
  4. 15244
  5. 15245
  6. 15246

    Blockage of mechanosensitive Piezo1 channel alleviates the severity of experimental malaria-associated acute lung injury by Min Zhang, Qian Ru Wang, Xinpeng Hou, Qi Wang, Xiaoyan Yang, Tingting Zhou, Xiaobo Liu, Lirong Wu, Jie Wang, Xiaobao Jin, Zhenlong Liu, Bo Huang

    Published 2024-02-01
    “…Methods Here, we utilized a widely accepted murine model of MA-ALI using C57BL/6 mice with Plasmodium berghei ANKA infection and then added a Piezo1 inhibitor (GsMTx4) to the model. …”
    Get full text
    Article
  7. 15247

    Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, d... by Alassane Dicko, Abdoulbaki I Diallo, Intimbeye Tembine, Yahia Dicko, Niawanlou Dara, Youssoufa Sidibe, Gaoussou Santara, Halimatou Diawara, Toumani Conaré, Abdoulaye Djimde, Daniel Chandramohan, Simon Cousens, Paul J Milligan, Diadier A Diallo, Ogobara K Doumbo, Brian Greenwood

    Published 2011-02-01
    “…A total of 672 episodes of clinical malaria defined as fever or a history of fever and the presence of at least 5,000 asexual forms of Plasmodium falciparum per microlitre (incidence rate of 1.90; 95% confidence interval [CI] 1.76-2.05 episodes per person year) were observed in the control arm versus 126 (incidence rate of 0.34; 95% CI 0.29-0.41 episodes per person year) in the intervention arm, indicating a protective effect (PE) of 82% (95% CI 78%-85%) (p<0.001) on the primary endpoint. …”
    Get full text
    Article
  8. 15248

    Imported malaria cases in former endemic and non-malaria endemic areas in China: are there differences in case profile and time to response? by Shao-Sen Zhang, Jun Feng, Li Zhang, Xiang Ren, Elizabeth Geoffroy, Sylvie Manguin, Roger Frutos, Shui-Sen Zhou

    Published 2019-07-01
    “…Variables used in the comparative analysis between cases in former endemic and former non-endemic areas, included age, gender and occupation, destination of overseas travel, Plasmodium species and patient health outcome. Monthly aggregated data was used to compare seasonal and spatial characteristics. …”
    Get full text
    Article
  9. 15249

    Identification and characterization of novel chemical scaffolds to overcome drug resistance in malaria by Tay, Donald Wen Jun

    Published 2020
    “…By comparison of pharmacokinetic properties in humans against their efficacy against Plasmodium falciparum, this allowed us to shortlist the two candidates which were documented to achieve doses in excess of their minimum inhibitory concentrations for at least 24hrs post administration in a single dose. …”
    Get full text
    Thesis-Doctor of Philosophy
  10. 15250

    Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, random... by Peto, TJ, Tripura, R, Callery, JJ, Lek, D, Nghia, HDT, Nguon, C, Thuong, NTH, van der Pluijm, RW, Dung, NTP, Sokha, M, Luong, VV, Long, LT, Sovann, Y, Duanguppama, J, Waithira, N, Hoglund, RM, Chotsiri, P, Chau, NH, Ruecker, A, Amaratunga, C, Dhorda, M, Miotto, O, Maude, RJ, Rekol, H, Chotivanich, K, Tarning, J, von Seidlein, L, Imwong, M, Mukaka, M, Day, NPJ, Hien, TT, White, NJ, Dondorp, AM

    Published 2022
    “…Eligible participants were male and female patients aged 2–65 years with uncomplicated <i>Plasmodium falciparum</i> malaria. Patients were randomly allocated (1:1 in blocks of eight to 12) to either artemether–lumefantrine alone (dosed according to WHO guidelines) or artemether–lumefantrine plus amodiaquine (10 mg base per kg/day), both given orally as six doses over 3 days. …”
    Journal article
  11. 15251

    Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patie... by Abdulla, S, Adam, I, Adjei, G, Adjuik, M, Alemayehu, B, Allan, R, Arinaitwe, E, Ashley, E, Ba, MS, Barennes, H, Barnes, K, Bassat, Q, Baudin, E, Berens-Riha, N, Bjoerkman, A, Bompart, F, Bonnet, M, Borrmann, S, Bousema, T, Brasseur, P, Bukirwa, H, Checchi, F, Dahal, P, D'Alessandro, U, Desai, M, Dicko, A, Djimde, A, Dorsey, G, Doumbo, O, Drakeley, C, Duparc, S, Eshetu, T, Espie, E, Etard, J, Faiz, A, Falade, C, Fanello, C, Faucher, J, Faye, B, Faye, O, Filler, S, Flegg, J, Fofana, B, Fogg, C, Gadalla, N, Gaye, O, Genton, B, Gething, P, Gil, J, Gonzalez, R, Grandesso, F, Greenhouse, B, Greenwood, B, Grivoyannis, A, Guerin, P, Guthmann, J, Hamed, K, Hamour, S, Hay, S, Hodel, E, Humphreys, G, Hwang, J, Ibrahim, M, Jima, D, Jones, J, Jullien, V, Juma, E, Kachur, P, Kager, P, Kamugisha, E, Kamya, MR, Karema, C, Kayentao, K, Kiechel, J, Kironde, F, Kofoed, P, Kremsner, P, Krishna, S, Lameyre, V, Lell, B, Lima, A, Makanga, M, Malik, E, Marsh, K, Martensson, A, Massougbodji, A, Menan, H, Menard, D, Menendez, C, Mens, P, Meremikwu, M, Moreira, C, Nabasumba, C, Nambozi, M, Ndiaye, J, Ngasala, B, Nikiema, F, Nsanzabana, C, Ntoumi, F, Oguike, M, Ogutu, B, Olliaro, P, Omar, SA, Ouedraogo, J, Owusu-Agyei, S, Penali, L, Pene, M, Peshu, J, Piola, P, Plowe, C, Premji, Z, Price, R, Randrianarivelojosia, M, Rombo, L, Roper, C, Rosenthal, P, Sagara, I, Same-Ekobo, A, Sawa, P, Schallig, H, Schramm, B, Seck, A, Shekalaghe, SA, Sibley, C, Sinou, V, Sirima, S, Som, F, Sow, D, Staedke, S, Stepniewska, K, Sutherland, C, Swarthout, T, Sylla, K, Talisuna, A, Taylor, W, Temu, E, Thwing, J, Tine, R, Tinto, H, Tommasini, S, Toure, O, Ursing, J, Vaillant, M, Valentini, G, Van den Broek, I, Van Vugt, M, Ward, SA, Winstanley, P, Yavo, W, Yeka, A, Zolia, Y, Zongo, I, Based, W

    Published 2015
    “…Background: Artemisinin-resistant Plasmodium falciparum has emerged in the Greater Mekong sub-region and poses a major global public health threat. …”
    Journal article
  12. 15252

    Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study by Ndila, C, Uyoga, S, Macharia, A, Nyutu, G, Peshu, N, Ojal, J, Shebe, M, Awuondo, K, Mturi, N, Tsofa, B, Sepúlveda, N, Clark, T, Band, G, Clarke, G, Rowlands, K, Hubbart, C, Jeffreys, A, Kariuki, S, Marsh, K, Mackinnon, M, Maitland, K, Kwiatkowski, D, Rockett, K, Williams, T, Malariagen Consortium

    Published 2018
    “…We investigated associations between multiple candidate polymorphisms-many related to the structure or function of red blood cells-and risk for severe Plasmodium falciparum malaria and its specific phenotypes, including cerebral malaria, severe malaria anaemia, and respiratory distress.We did a case-control study in Kilifi County, Kenya. …”
    Journal article
  13. 15253

    Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial by McLean, ARD, Indrasuta, C, Khant, ZS, Phyo, AK, Maung, SM, Heaton, J, Aung, H, Aung, Y, Soe, K, Swe, MMM, von Seidlein, L, Tun, NN, Tun, KM, Day, NPJ, Ashley, EA, Hlaing, T, Kyaw, TT, Dondorp, AM, Imwong, M, White, NJ, Smithuis, FM

    Published 2021
    “…<p><strong>Background:</strong> To contain multidrug-resistant Plasmodium falciparum, malaria elimination in the Greater Mekong subregion needs to be accelerated while current antimalarials remain effective. …”
    Journal article
  14. 15254

    Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: Cross-sectional and case-control studies by Ngugi, A, Bottomley, C, Kleinschmidt, I, Wagner, R, Kakooza-Mwesige, A, Ae-Ngibise, K, Owusu-Agyei, S, Masanja, H, Kamuyu, G, Odhiambo, R, Chengo, E, Sander, J, Newton, C

    Published 2013
    “…Blood samples were taken from a randomly selected subgroup of 300 participants with epilepsy and 300 control individuals from each centre and were screened for antibodies to Toxocara canis, Toxoplasma gondii, Onchocerca volvulus, Plasmodium falciparum, Taenia solium, and HIV. We estimated odds ratios (ORs) with logistic regression, adjusted for age, sex, education, employment, and marital status. …”
    Journal article
  15. 15255

    The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data by Adjuik, M, Allan, R, Anvikar, A, Ashley, E, Ba, MS, Barennes, H, Barnes, K, Bassat, Q, Baudin, E, Bjorkman, A, Bompart, F, Bonnet, M, Borrmann, S, Brasseur, P, Bukirwa, H, Checchi, F, Cot, M, Dahal, P, D'Alessandro, U, Deloron, P, Desai, M, Diap, G, Djimde, A, Dorsey, G, Doumbo, O, Espie, E, Etard, J, Fanello, C, Faucher, J, Faye, B, Flegg, J, Gaye, O, Gething, P, Gonzalez, R, Grandesso, F, Guerin, P, Guthmann, J, Hamour, S, Hasugian, A, Hay, S, Humphreys, G, Jullien, V, Juma, E, Kamya, MR, Karema, C, Kiechel, JR, Kremsner, P, Krishna, S, Lameyre, V, Ibrahim, L, Lee, S, Lell, B, Martensson, A, Massougbodji, A, Menan, H, Menard, D, Menendez, C, Meremikwu, M, Moreira, C, Nabasumba, C, Nambozi, M, Ndiaye, J, Nikiema, F, Nsanzabana, C, Ntoumi, F, Ogutu, B, Olliaro, P, Osorio, L, Ouedraogo, J, Penali, L, Pene, M, Pinoges, L, Piola, P, Price, R, Roper, C, Rosenthal, P, Rwagacondo, C, Same-Ekobo, A, Schramm, B, Seck, A, Sharma, B, Sibley, C, Sinou, V, Sirima, S, Smith, J, Smithuis, F, Some, F, Sow, D, Staedke, S, Stepniewska, K, Swarthout, T, Sylla, K, Talisuna, A, Tarning, J, Taylor, W, Temu, E, Thwing, J, Tjitra, E, Tine, R, Tinto, H, Vaillant, M, Valecha, N, Van den Broek, I, White, N, Yeka, A, Zongo, I, Resistance, W

    Published 2015
    “…Background: Artesunate-amodiaquine (AS-AQ) is one of the most widely used artemisinin-based combination therapies (ACTs) to treat uncomplicated Plasmodium falciparum malaria in Africa. We investigated the impact of different dosing strategies on the efficacy of this combination for the treatment of falciparum malaria. …”
    Journal article
  16. 15256
  17. 15257
  18. 15258
  19. 15259
  20. 15260